J Korean Cleft Palate-Craniofac Assoc Search

CLOSE


Arch Craniofac Surg > Epub ahead of print
Sakarinpanichakul: Outcomes of the modified neurovascular cheek flap compared with nasolabial flap in lower lip reconstruction: a retrospective cohort analysis

Abstract

Background

Lower lip reconstruction following cancer resection commonly employs the nasolabial flap (NLF) or modified neurovascular cheek flap (MNCF). Both techniques inadequately restore the orbicularis oris sphincter, theoretically predisposing patients to oral incompetence and drooling. However, direct comparative data on functional outcomes remain limited. To compare the incidence of postoperative drooling and wound complications between NLF and MNCF reconstruction for lower lip defects.

Methods

This retrospective cohort study included 125 patients with lower lip squamous cell carcinoma who underwent reconstruction with either NLF (n= 47) or MNCF (n= 78) between August 2012 and August 2025 at a single tertiary center. The primary outcome was drooling at the 3-month follow-up. Secondary outcomes included overall wound complications within 30 days. Multivariate logistic regression was performed to adjust for confounders.

Results

Baseline characteristics were comparable except for defect size, which was significantly larger in the MNCF group (75.0% vs. 60.0%; p= 0.007), and flap laterality, with bilateral procedures more common in the MNCF group (56.4% vs. 12.8%; p< 0.001). The overall drooling rate was 14.4%, with no significant difference between groups in univariate analysis (MNCF 11.5% vs. NLF 19.1%; p= 0.240). However, after adjusting for confounders, including flap laterality, the MNCF demonstrated a significantly lower risk of drooling (adjusted odds ratio [OR], 0.18; 95% confidence interval [CI], 0.04–0.82; p= 0.026). The MNCF group also showed significantly lower complication rates (1.3% vs. 14.9%, p= 0.003; adjusted OR, 0.06; 95% CI, 0.01–0.76; p= 0.030).

Conclusion

The MNCF is associated with significantly lower rates of drooling and wound complications than the NLF, despite reconstructing larger defects. After controlling for flap laterality, the MNCF demonstrates superior functional outcomes, establishing it as the preferred technique for extensive lower lip reconstruction when surgical expertise is available.

Abbreviations

AUC

area under the curve

CI

confidence interval

IQR

interquartile range

MNCF

modified neurovascular cheek flap

MRND

modified radical neck dissection

NLF

nasolabial flap

OR

odds ratio

ROC

receiver operating characteristic

INTRODUCTION

Lip carcinoma is the most prevalent form of malignancy in the head and neck region, representing roughly 25% to 30% of all oral cancers. Importantly, around 90% of these cancers of the lip develop on the lower lip [1]. The fundamental principle of surgical management of lip cancer is the complete excision of the tumor with a safe margin, typically 0.5–1 cm of surrounding tissue [2]. Following resection, the resulting defect and loss of lip substance necessitate reconstructive surgery. The goals of lip reconstruction are multifaceted, encompassing both the restoration of oral function and the achievement of an acceptable aesthetic outcome [3]. The size and location of the defect primarily determine the choice of an appropriate reconstructive technique. If a full-thickness lower lip defect involves less than one-third of the total lower lip length, primary closure can often be performed without significant functional compromise. However, defects involving more than one-third of the lip length preclude direct closure and require more complex reconstructive procedures to replace the missing tissue [4].
Several surgical options are available for reconstructing such lower lip defects, including the nasolabial flap (NLF), Karapandzic flap, Abbe-Estlander flap, Gillies fan flap, Bernard-Webster flap, and the Fujimori gate flap, among others [5]. The NLF is a widely used and reliable technique for lower lip reconstruction. However, it has several recognized drawbacks. A primary functional limitation is its inability to reconstruct the native orbicularis oris muscle complex. As a non-sphincteric replacement, it fails to restore dynamic circumoral function, a key factor theorized to contribute to postoperative complications such as oral incompetence and drooling [6,7]. Additional concerns include a conspicuous facial scar, which can be a significant cosmetic issue for younger patients, and potential asymmetry in cases of unilateral reconstruction [8]. The modified neurovascular cheek flap (MNCF), described by Chowchuen et al. [9-12], offers an alternative approach. This technique is an adaptation of the method reported by Vatanasapt et al. in 1987, as cited in Chowchuen et al. [9]. The MNCF is versatile and can be employed to reconstruct both upper and lower lip defects, ranging from those larger than one-third of the lip length to subtotal or total lip defects, unilaterally or bilaterally [10-12]. While it aims to provide a more anatomical reconstruction, it is not without its own limitations. The incision creates a scar across the natural skin lines of the cheek, and similar to the NLF, it does not fully reconstitute the complete, functional orbicularis oris sphincter.
Theoretically, both the NLF and MNCF, by virtue of not fully restoring the muscular sphincter, carry a risk of impairing oral competence and leading to drooling. At our institution, these two techniques collectively account for over 90% of major lower lip reconstructions. Despite their prevalent use, a direct comparative analysis of their functional outcomes, particularly the incidence of drooling, is lacking in the literature. This study aims to fill this critical knowledge gap. The primary objective is to directly compare the functional outcomes of the NLF and MNCF techniques, specifically focusing on the rate of postoperative drooling. The secondary aim is to compare overall wound complication rates, including dehiscence, infection, and flap necrosis, between the two techniques.

METHODS

Study design

This study employed a retrospective cohort design to compare surgical outcomes between two reconstructive techniques for lower lip reconstruction: the MNCF and the NLF. The study was conducted in accordance with the principles of the Declaration of Helsinki and received Institutional Ethics Committee approval before data collection.

Ethical considerations

The Institutional Review Board (IRB) of Buriram Hospital reviewed and approved the study protocol (Protocol No. BR 0033.102.1/76; Approval date: November 4, 2025). Given that the research consisted of a retrospective analysis of already existing, anonymized medical records, the ethics committee waived the need for individual informed consent. During data collection, all patient information was meticulously de-identified to maintain confidentiality and privacy. Only the principal investigator had access to the raw data.

Study setting and participant selection

This study was conducted at a single tertiary care center in Thailand. It included a comprehensive review of all adult patients (≥18 years) who underwent lower lip reconstruction following oncologic resection for histologically confirmed squamous cell carcinoma between Aug 1, 2012, and Aug 31, 2025. Patients were excluded if they had incomplete medical records, died within 90 days from causes unrelated to the reconstructive procedure, had a history of prior head and neck radiation or major surgery that could alter local anatomy, or had pre-existing neurological disorders or facial nerve palsy that could independently influence oral competence and drooling.

Sample size calculation

The sample size was calculated a priori for the primary outcome (incidence of drooling) using a two-sample proportion comparison formula. The estimated drooling rate for the NLF group was 13.2%, derived from a study by Agarwal et al. [7] which specifically reported this outcome. For the MNCF group, no prior studies have reported drooling rates specific to this technique. Therefore, a conservative estimate was derived using available literature on non-sphincteric local advancement flaps for lower lip reconstruction. In particular, the study by Kim et al. [13], which evaluated functional outcomes following a mental V-Y advancement flap, served as a reference. Although the direction of advancement in that technique differs from the lateral advancement employed in the MNCF, both procedures represent non-sphincteric local advancement flaps that do not restore the circular orbicularis oris sphincter. This estimate was used solely for sample size calculation to ensure adequate statistical power in the absence of technique-specific data.
To achieve a significance level (α) of 0.05 (two-tailed) and a statistical power (1-β) of 80%, a minimum of 42 patients per group was required. Given an estimated dropout rate of 10%, the final target sample size was set at 47 patients per group. A retrospective review identified 78 eligible patients in the MNCF cohort and 47 in the NLF cohort, both of which exceeded the calculated minimum requirement.

Surgical techniques

The two surgical techniques compared in this study are established procedures for lower lip reconstruction at our institution.

Nasolabial flap

The NLF procedure was performed according to standard techniques [6-8]. An inferiorly-based flap was designed along the nasolabial fold and raised in the supramuscular plane, preserving the subdermal plexus. The flap was transposed to reconstruct the lip defect after appropriate de-epithelialization at the pedicle. The donor site was closed primarily (Fig. 1).

Modified neurovascular cheek flap

The MNCF procedure was performed as previously described by Chowchuen et al. [9-12]. Briefly, the technique involves designing a V-shaped skin and mucosal flap from the cheek, preserving the neurovascular structures through careful blunt dissection. The flap is then advanced to reconstruct the lip defect, with meticulous reapproximation of the orbicularis oris and facial muscles to restore oral competence. Special attention is paid to identifying and preserving the main trunk of the facial artery and its accompanying venae comitantes, which serve as the vascular pedicle of the flap, as well as the parotid duct (Fig. 2).

Data collection and outcome measures

Data were collected retrospectively from electronic medical records, operative notes, pathology reports, and clinical photographs using a standardized data collection form. The primary outcome was postoperative drooling, assessed at the 3-month follow-up visit. Drooling was defined as any unintentional leakage of saliva from the mouth and was recorded in the medical charts as either present or absent based on clinical assessment. Secondary outcomes included the overall rate of wound complications within 30 days after surgery. This evaluation specifically included flap necrosis (either partial or total), wound dehiscence, and surgical site infection.

Data variables

The extracted baseline and potential confounding variables included patient demographics (age, sex, and body mass index); comorbidities (diabetes, hypertension, chronic kidney disease, and other medical conditions); behavioral factors (smoking and alcohol use); tumor-related characteristics (tumor volume, anatomical location, and pathological stage); surgical factors including flap laterality and the performance of modified radical neck dissection (MRND); and functional variables such as time to full oral intake. Surgical defect size was recorded as the proportion of the total lower lip length.

Statistical analysis

Statistical analysis was conducted using JASP (version 0.95.2.0). Continuous variables were reported as mean±standard deviation or median with interquartile range (IQR), depending on the results of normality testing (Shapiro-Wilk test). Categorical variables were reported as frequencies and percentages. To compare groups, we used independent t-tests or Mann-Whitney U tests for continuous data and chi-square tests or Fisher exact tests for categorical data. Multivariable logistic regression was employed to evaluate the independent association between flap type and outcomes, adjusting for clinically relevant variables and those with baseline imbalances (p<0.10). Results were presented as adjusted odds ratios (aORs) with 95% confidence intervals (CIs), and the area under the curve (AUC) was used to assess model discrimination. Statistical significance was determined at p<0.05 (two-tailed).

RESULTS

Study population

A retrospective review identified 138 patients who underwent lower lip reconstruction following cancer resection between August 2012 and August 2025. After excluding 13 patients with incomplete medical records, 125 patients met the inclusion criteria and comprised the final study cohort. The patient selection process is detailed in Fig. 3. Among them, 47 patients (37.6%) underwent NLF reconstruction, and 78 patients (62.4%) underwent MNCF.

Baseline characteristics and tumor profiles

The baseline demographic, clinical, and tumor characteristics of the two groups are summarized in Table 1. The groups were well-balanced in terms of age (NLF 71.3±8.1 years vs. MNCF 73.2±8.9 years; p=0.244), sex (female: 91.5% vs. 89.7%; p=0.748), and comorbidities. However, the MNCF group had a significantly larger surgical defect size, with a median of 75.0% (IQR, 60.0%–90.0%) compared to 60.0% (IQR, 55.0%–75.0%) in the NLF group (p=0.007) (Fig. 4). Bilateral flap reconstruction was significantly more common in the MNCF group, occurring in 56.4% of cases compared to 12.8% in the NLF group (p<0.001). The distribution of T-stage (p=0.248) and N-stage (p=0.062) did not differ significantly between the groups, indicating that the tumor severity at presentation was comparable.

Primary outcome: drooling incidence

The overall drooling rate was 14.4% (18/125). The MNCF group demonstrated a lower drooling rate (11.5%, 9/78) compared to the NLF group (19.1%, 9/47), although this difference did not reach statistical significance (OR, 0.55; 95% CI, 0.20–1.51; p=0.240) (Table 2). After adjusting for potential confounders, including age, defect size, tumor location, MRND, time to full oral intake, and flap laterality in multivariate logistic regression analysis (Table 3, Fig. 5A), the MNCF demonstrated significantly lower drooling risk (aOR, 0.18; 95% CI, 0.04–0.82; p=0.026). The model showed good discriminative ability (AUC=0.749) (Fig. 6A). Notably, while flap laterality (bilateral vs. unilateral) showed a trend toward increased drooling risk, this did not reach statistical significance (aOR, 5.59; 95% CI, 0.68–46.12; p=0.110).

Secondary outcomes: complication rates

The MNCF group exhibited a significantly lower overall complication rate of 1.3% (1 out of 78) compared to the NLF group, which had a complication rate of 14.9% (7 out of 47) (OR, 0.07; 95% CI, 0.01–0.62; p=0.003) (Table 2). Complications in the NLF group included three cases of wound dehiscence, two cases of partial flap necrosis, one case of total flap necrosis, and one case of wound infection. In contrast, the MNCF group experienced only one instance of wound infection. Multivariate logistic regression analysis (Table 4, Fig. 5B) confirmed that the MNCF technique was independently associated with a lower risk of complications after adjusting for factors such as age, defect size, tumor location, MRND, time to full oral intake, and flap laterality (aOR, 0.06; 95% CI, 0.01–0.76; p=0.030). The model demonstrated excellent discriminative ability with an AUC of 0.855 (Fig. 6B). While MRND was associated with a strong trend towards higher complications, it did not reach statistical significance (aOR, 7.39; 95% CI, 0.94–58.21; p=0.057). Additionally, flap laterality was not independently associated with complications (p=0.753).

Clinical outcomes of MNCF reconstruction

Representative clinical outcomes from three patients who underwent reconstruction using the MNCF are shown in Figs. 7-9. These cases demonstrate satisfactory restoration of lip contour and oral competence following reconstruction.

DISCUSSION

This retrospective cohort study provides the first direct comparison of functional and surgical outcomes between the MNCF and the NLF for lower lip reconstruction following oncologic resection. Despite being applied to significantly larger defects and more frequently in bilateral configurations, the MNCF demonstrated lower postoperative drooling and wound complication rates.
The overall drooling rate in this cohort was 14.4%, comparable to previously published data [7]. Although univariate analysis did not reveal a statistically significant difference, multivariate analysis demonstrated a strong protective effect of the MNCF (aOR, 0.18; p=0.026). This finding highlights the critical importance of adjusting for confounders, particularly flap laterality, to reveal the true functional advantage of the technique masked by clinical practice patterns.
The favorable continence observed with the MNCF, despite significantly larger reconstructed defects (median 75.0% vs. 60.0%; p=0.007), warrants further attention. Several anatomical characteristics may explain this outcome. First, bilateral advancement provides symmetrical tissue bulk and preserves lip height and commissure position, facilitating passive lip seal [11,12]. Second, preservation of sensory innervation through the buccal nerve branches enhances saliva detection and compensatory swallowing responses [11,12,14]. Third, cheek tissue more closely approximates the biomechanical properties of native lip tissue than nasolabial skin [14,15]. Because neither technique restores circumferential orbicularis oris contraction [7,8,11,12], postoperative continence depends largely on tissue bulk, lip eversion, and sensory feedback rather than active sphincteric function [12]. The three-month assessment period may therefore reflect the stage at which sensory recovery and adaptive swallowing mechanisms become functionally evident [16,17].
The MNCF was also associated with substantially lower complication rates (1.3% vs. 14.9%: aOR, 0.06; p=0.030) despite being used for larger defects and more frequent bilateral reconstructions— factors typically associated with increased risk [14,18]. This advantage likely reflects both anatomical and technical aspects. The multilayered composition of the MNCF, incorporating skin, subcutaneous tissue, muscle, and mucosa, provides robust neurovascular pedicles and vascular redundancy [11,12]. In contrast, the thinner NLF relies primarily on a narrower subdermal plexus [7,19]. In addition, direct advancement with the MNCF avoids mechanical vulnerabilities inherent to flap rotation, such as pedicle torsion and venous congestion [7,8,19,20]. Bilateral MNCF reconstruction may more evenly distribute tension across the defect [11,12]. Consistent with this, our analysis confirmed that flap laterality itself was not an independent risk factor (p=0.753). In contrast, the trend toward increased complications with MRND (p=0.057) likely reflects greater operative magnitude rather than flap choice [21].
Beyond nasolabial and cheek-based advancement flaps, rotation-advancement techniques such as Karapandzic and Gillies fan flaps represent another major option for lower lip defects exceeding one-third of the lip length [4,5]. These techniques preserve the orbicularis oris muscle and neurovascular supply, theoretically restoring dynamic sphincteric function [5,16]. However, the Karapandzic flap carries a high risk of microstomia and commissure distortion, particularly in larger defects, which can compromise denture usage and oral hygiene [5]. Similarly, the standard Gillies fan flap may cause commissure blunting and is typically insensate unless modified [15,16].
Within this reconstructive landscape, the MNCF offers complementary advantages. Unlike rotation flaps, which prioritize sphincter restitution at the potential expense of the oral aperture, the MNCF’s lateral advancement preserves the oral aperture and minimizes microstomia [11,12]. Compared with the insensate NLF or standard Gillies flap, the MNCF reliably preserves sensory function via buccal nerve branches, facilitating passive oral competence [12,14]. Bilateral advancement extends its applicability to near-total defects [11,12]. Although the MNCF does not restore active circumferential sphincter contraction, the combined preservation of sensation, tissue bulk, and lip height provides acceptable functional outcomes, particularly in significant, central, or bilateral defects where rotation-advancement flaps may be less suitable. These techniques should be viewed as complementary rather than competing, with flap selection guided by defect characteristics, oncologic considerations, and surgical expertise.
This study holds several clinical implications. The emergence of the MNCF’s protective effect only after multivariate adjustment underscores the importance of accounting for defect size and flap laterality in reconstructive outcome analysis. These findings support the feasibility of wider oncologic resections when adequate MNCF expertise is available, without compromising functional outcomes. Strengths of this study include the first direct comparison of postoperative drooling between these techniques, a sufficient sample size, and comprehensive adjustment for confounders.
Several limitations should be acknowledged. First, the retrospective design introduces potential selection bias and residual confounding despite multivariate adjustment. Second, postoperative drooling was assessed as a dichotomous clinical variable (present/absent) rather than using a validated quantitative scale [17]. This limitation lacks sensitivity for severity grading and potentially underrepresents subtle functional deficits. Finally, this single-center experience reflects substantial institutional familiarity with the MNCF technique [11,12]. The superior outcomes observed may reflect learning curve effects, which may limit generalizability to centers less experienced with this specific flap. Future prospective studies incorporating validated quality-of-life instruments are warranted to validate these findings.
In conclusion, after adjustment for confounders, including flap laterality, the MNCF demonstrated significantly lower rates of postoperative drooling and wound complications compared with the NLF, despite reconstructing larger defects. These findings support the MNCF as a preferred reconstructive option for extensive lower lip defects when appropriate surgical expertise is available.

Notes

Conflict of interest

No potential conflict of interest relevant to this article was reported.

Funding

None.

Acknowledgements

The author wishes to thank Dr. Watchara Burapholkul, M.D. (Department of Surgery, Buriram Hospital, Buri Ram, Thailand), a highly experienced plastic surgeon, for his invaluable assistance with data acquisition and consultation regarding research outcome measurements.

Ethical approval

The Institutional Review Board of Buriram Hospital approved the study (Protocol No. BR 0033.102.1/76; November 4, 2025) and waived the requirement for informed consent due to the retrospective nature of the study.

Patient consent

The patients provided written informed consent for the publication and use of their images.

Fig. 1.
A 59-year-old woman diagnosed with left-sided lower lip squamous cell carcinoma (T1N0M0) underwent wide excision and nasolabial flap (NLF) coverage. Preoperative views of the patient and the intraoral lesion are shown. Following tumor resection, a post-resection defect was observed. The design of the NLF was marked, and the harvested flap was inset to reconstruct the defect. The final image shows the postoperative appearance at the 18-month follow-up.
acfs-2025-0086f1.jpg
Fig. 2.
An 80-year-old woman diagnosed with central lower lip squamous cell carcinoma (T1N0M0) underwent wide excision and modified neurovascular cheek flap coverage. The images show the preoperative facial view, the post-resection defect following tumor removal, marking of the modified neurovascular cheek flap and facial artery, and marking of the intraoral side. The harvested flap and the immediate postoperative appearance after flap inset are also shown. The final image demonstrates the postoperative result at 1 month.
acfs-2025-0086f2.jpg
Fig. 3.
Patient flow diagram showing study enrollment, exclusion, and final allocation to the NLF and MNCF groups. NLF, nasolabial flap; MNCF, modified neurovascular cheek flap.
acfs-2025-0086f3.jpg
Fig. 4.
Distribution of defect size by reconstruction technique. Violin and box plots demonstrating defect size (% of total lower lip length) for the NLF (n=47) and MNCF (n=78) groups. Individual data points are displayed as dots. The box represents the interquartile range, and the horizontal line indicates the median. NLF, nasolabial flap; MNCF, modified neurovascular cheek flap.
acfs-2025-0086f4.jpg
Fig. 5.
Forest plots of multivariate analyses. (A) Adjusted odds ratios for factors associated with postoperative drooling. (B) Adjusted odds ratios for factors related to overall complications. MNCF, modified neurovascular cheek flap; NLF, nasolabial flap; MRND, modified radical neck dissection; OR, odds ratio; CI, confidence interval.
acfs-2025-0086f5.jpg
Fig. 6.
Receiver operating characteristic (ROC) curves for multivariate prediction models. (A) ROC curve of the drooling prediction model. (B) ROC curve of the overall complication prediction model. Both models included flap type, age, defect size, tumor location, flap laterality, modified radical neck dissection status, and time to full oral intake. AUC, area under the curve.
acfs-2025-0086f6.jpg
Fig. 7.
A 74-year-old woman with squamous cell carcinoma of the left lower lip (1.7×1.5×1.1 cm, T1N0M0) underwent reconstruction with a modified neurovascular cheek flap following tumor excision, resulting in a 50% lower lip defect. (A) Preoperative views showing oral aperture during mouth opening (width 5.5 cm, height 4.0 cm). (B) Postoperative views at 4 months demonstrating preserved mouth opening with unchanged dimensions and good oral competence without drooling or complications.
acfs-2025-0086f7.jpg
Fig. 8.
A 69-year-old woman with squamous cell carcinoma involving the central and left lower lip (2.2×1.3×1.5 cm, T2N0M0) underwent reconstruction with bilateral modified neurovascular cheek flaps following tumor excision, resulting in a 100% lower lip defect. (A) Preoperative views showing oral aperture during mouth opening (width 4.0 cm, height 3.5 cm). (B) Postoperative views at 12 months demonstrating preserved mouth opening with unchanged dimensions and good oral competence without drooling or complications.
acfs-2025-0086f8.jpg
Fig. 9.
An 83-year-old woman with squamous cell carcinoma of the central lower lip (4.2×2.0×1.0 cm, T3N0M0) underwent reconstruction with bilateral modified neurovascular cheek flaps following tumor excision, resulting in an 80% lower lip defect. (A) Preoperative views showing oral aperture during mouth opening (width 6.5 cm, height 4.0 cm). (B) Postoperative views at 6 months demonstrating preserved mouth opening with unchanged dimensions and good oral competence without drooling or complications.
acfs-2025-0086f9.jpg
Table 1.
Patient demographics and clinical characteristics
Variable NLF (n= 47) MNCF (n= 78) p-value
Age (yr), mean ± SD 71.3 ± 8.1 73.2 ± 8.9 0.244a)
Sex, No. (%) 0.748
 Female 43 (91.5) 70 (89.7)
 Male 4 (8.5) 8 (10.3)
Body mass index (kg/m²), median (IQR) 21.4 (19.3–23.4) 21.0 (18.7–22.9) 0.490b)
Smoking, No. (%) 3 (6.4) 4 (5.1) 0.768
Alcohol, No. (%) 4 (8.5) 5 (6.4) 0.660
Diabetes mellitus, No. (%) 8 (17.0) 12 (15.4) 0.809
Comorbidity, No. (%) 22 (46.8) 34 (43.6) 0.726
Tumor volume (cm³), median (IQR) 4.6 (2.5–9.8) 6.1 (3.2–12.6) 0.269b)
Defect size (%), median (IQR) 60.0 (55.0–75.0) 75.0 (60.0–90.0) 0.007b),c)
Tumor location, No. (%) 0.019c)
 Lateral (left) 20 (42.6) 27 (34.6)
 Lateral (right) 14 (29.8) 11 (14.1)
 Central 13 (27.7) 40 (51.3)
Flap laterality, No. (%) < 0.001c)
 Unilateral 41 (87.2) 34 (43.6)
 Bilateral 6 (12.8) 44 (56.4)
T stage, No. (%) 0.248
 Early (T1-T2) 37 (78.7) 54 (69.2)
 Advanced (T3-T4) 10 (21.3) 24 (30.8)
N stage, No. (%) 0.062
 N0 41 (87.2) 75 (96.2)
 N+ 6 (12.8) 3 (3.8)
MRND performed, No. (%) 6 (12.8) 3 (3.8) 0.062
Time to full oral intake (day), median (IQR) 4.0 (3.0–5.5) 5.0 (4.0–6.0) 0.022b),c)
Follow-up (mo), median (IQR) 15.0 (7.5–38.0) 14.5 (5.0–36.0) 0.959b)

NLF, nasolabial flap; MNCF, modified neurovascular cheek flap; SD, standard deviation; IQR, interquartile range; MRND, modified radical neck dissection.

a) Independent t-test (normal distribution);

b) Mann-Whitney U test (non-normal distribution);

c) p<0.05; Other categorical variables: chi-square or Fisher exact test; continuous variables: independent t-test.

Table 2.
Primary and secondary outcomes
Outcome NLF (n= 47) MNCF (n= 78) OR (95% CI) p-value
Primary outcome
 Drooling 9 (19.1) 9 (11.5) 0.55 (0.20–1.51) 0.240
Secondary outcome
 Overall complication 7 (14.9) 1 (1.3) 0.07 (0.01–0.62) 0.003a)
 Wound dehiscence 3 0
 Wound infection 2 1
 Partial flap necrosis 1 0
 Total flap necrosis 1 0

Values are presented as number (%).

NLF, nasolabial flap; MNCF, modified neurovascular cheek flap; OR, odds ratio; CI, confidence interval.

a) Statistical significance (p<0.05).

Table 3.
Multivariate logistic regression analysis for drooling
Variable Adjusted OR (95% CI) p-value
Flap type (MNCF vs. NLF) 0.18 (0.04–0.82) 0.026a)
Age (per year) 1.02 (0.96–1.09) 0.545
Defect size (per %) 1.01 (0.96–1.05) 0.845
Location (lateral right vs. lateral left) 1.69 (0.29–9.92) 0.559
Location (central vs. lateral left) 1.68 (0.30–9.41) 0.556
Flap laterality (bilateral vs. unilateral) 5.59 (0.68–46.12) 0.110
MRND (yes vs. no) 1.23 (0.17–8.95) 0.841
Time to full oral intake (per day) 1.10 (0.93–1.29) 0.265

Model fit: Δχ²=17.0 (p=0.030), AUC=0.749, McFadden R²=0.165.

OR, odds ratio; CI, confidence interval; MNCF, modified neurovascular cheek flap; NLF, nasolabial flap; MRND, modified radical neck dissection; AUC, area under the curve.

a) Statistical significance (p<0.05).

Table 4.
Multivariate logistic regression analysis for overall complications
Variable Adjusted OR (95% CI) p-value
Flap type (MNCF vs. NLF) 0.18 (0.04–0.82) 0.026a)
Age (per year) 1.02 (0.96–1.09) 0.545
Defect size (per %) 1.01 (0.96–1.05) 0.845
Location (lateral right vs. lateral left) 1.69 (0.29–9.92) 0.559
Location (central vs. lateral left) 1.68 (0.30–9.41) 0.556
Flap laterality (bilateral vs. unilateral) 5.59 (0.68–46.12) 0.110
MRND (yes vs. no) 1.23 (0.17–8.95) 0.841
Time to full oral intake (per day) 1.10 (0.93–1.29) 0.265

Model fit: Δχ²=15.2 (p=0.056), AUC=0.855, McFadden R²=0.255.

OR, odds ratio; CI, confidence interval; MNCF, modified neurovascular cheek flap; NLF, nasolabial flap; MRND, modified radical neck dissection; AUC, area under the curve.

a) Statistical significance (p<0.05).

REFERENCES

1. Kilicarslan A, Tatli Dogan H. Clinical and pathological features of squamous cell carcinoma of the lip. Med J Islamic World Acad Sci 2018;26:41-5.
crossref
2. Lopez AC, Ruiz PC, Campo FJ, Gonzalez FD. Reconstruction of lower lip defects after tumor excision: an aesthetic and functional evaluation. Otolaryngol Head Neck Surg 2000;123:317-23.
crossref pmid pdf
3. Faulhaber J, Geraud C, Goerdt S, Koenen W. Functional and aesthetic reconstruction of full-thickness defects of the lower lip after tumor resection: analysis of 59 cases and discussion of a surgical approach. Dermatol Surg 2010;36:859-67.
crossref pmid
4. Coppit GL, Lin DT, Burkey BB. Current concepts in lip reconstruction. Curr Opin Otolaryngol Head Neck Surg 2004;12:281-7.
crossref pmid
5. Pribaz JJ, Buller M. Lip reconstruction. In: Neligan PC, Losee JE, Hopper R, editors. Plastic surgery. 5th ed. Elsevier; 2024. p. 256-74.

6. Tan NC, Hsieh CH, Riva FM, Jeng SF. The nasolabial flap as a one-stage procedure for reconstruction of intermediate-to-large lip defects with functional and aesthetic assessments. J Plast Reconstr Aesthet Surg 2013;66:352-7.
crossref pmid
7. Agarwal N, Kumbhat P, Agarwal S. Subcutaneous randomized nasolabial flap: our experience. Indian J Otolaryngol Head Neck Surg 2022;74:2236-40.
crossref pmid pmc pdf
8. Mishra A, Shankar R, Prakash G, Banerjee S, Daga D, Birmiwal KG, et al. Transposition nasolabial flap: a versatile flap for sensate reconstruction of lip defects. Head Neck 2022;44:2473-80.
crossref pmid pdf
9. Chowchuen B. Modified bilateral neurovascular cheek flaps: functional reconstruction of major upper lip defects. J Plas Reconstr Aesthet Surg Thai 1997;1:33-47.

10. Chowchuen B, Surakunprapha P. Modified bilateral neurovascular cheek flaps: a new technique for reconstruction of extensive upper lip defects. Ann Plast Surg 2001;47:64-9.
crossref pmid
11. Chowchuen B. Modified bilateral neurovascular cheek flaps: a new technique for reconstruction of difficult and extensive lower lip defect. J Med Assoc Thai 2012;95 Suppl 11:S164-7.
pmid
12. Chowchuen B. Modified bilateral neurovascular cheek flap: functional reconstruction of extensive lower lip defects. Plast Reconstr Surg Glob Open 2016;4:e721.
crossref pmid pmc
13. Kim JH, Ahn CH, Kim S, Lee WS, Oh SH. Effective method for reconstruction of remaining lower lip vermilion defect after a mental V-Y advancement flap. Arch Craniofac Surg 2019;20:76-83.
crossref pmid pmc pdf
14. Turgut G, Ozkaya O, Kayali MU, Tatlidede S, Huthut I, Bas L. Lower lip reconstruction with local neuromusculocutaneous advancement flap. J Plast Reconstr Aesthet Surg 2009;62:1196-201.
crossref pmid
15. Demirdover C, Vayvada H, Ozturk FA, Yazgan HS, Karaca C. A new modification of fan flap for large lower lip defects. Scand J Surg 2019;108:172-7.
crossref pmid pdf
16. Saraiya HA. Reconstruction of full-thickness lateral defect of the lower lip and vermilion with our modification of a fan flap: technique and results. Indian J Surg Oncol 2024;15:451-6.
crossref pmid pmc pdf
17. Sagar P, Handa KK, Gulati S, Kumar R. Submandibular duct re-routing for drooling in neurologically impaired children. Indian J Otolaryngol Head Neck Surg 2016;68:75-9.
crossref pmid pmc pdf
18. Papadopoulos O, Konofaos P, Tsantoulas Z, Chrisostomidis C, Frangoulis M, Karakitsos P. Lip defects due to tumor excision: apropos of 899 cases. Oral Oncol 2007;43:204-12.
crossref pmid
19. Abdelmaugood AA, Mazeed AS, Abdelmegeed AG, elsayed GY. The reliability and versatility of facial artery perforator-based nasolabial flaps in the reconstruction of lip defects. Egypt J Plast Reconstr Surg 2025;49:91-7.
crossref
20. Hakeem AH, Hakeem IH, Wani FJ. Inferiorly based nasolabial flap for reconstruction of the moderate to large defects of lips following cancer resection. Eur J Plast Surg 2016;39:187-92.
crossref pdf
21. Dedivitis RA, Guimaraes AV, Pfuetzenreiter EG, Castro MA. Neck dissection complications. Braz J Otorhinolaryngol 2011;77:65-9.
pmid pmc
TOOLS
Share :
Facebook Twitter Linked In Google+ Line it
METRICS Graph View
  • 0 Crossref
  •   Scopus
  • 212 View
  • 6 Download
Related articles in ACFS


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
AUTHOR INFORMATION
Editorial Office
Dept. of Plastic and Reconstructive Surgery Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Korea
Tel: +82-62-220-6354    Fax: +82-62-220-6357    E-mail: office_acfs@kcpca.or.kr                

Copyright © 2026 by Korean Association for Craniomaxillofacial Surgery (KACMFS).

Developed in M2PI

Close layer
prev next